Congress is about to vaporize a $28 billion hemp-derived THC industry that 225,000 Americans work in — and the only winner is the pharmaceutical establishment that hates competition.
The ban, tucked into a government spending measure by Sen. Mitch McConnell, would cap THC content in hemp products at 0.4 milligrams per container. That's not regulation; that's elimination. A typical hemp gummy on shelves today contains multiple milligrams. The 0.4-milligram limit makes virtually every product illegal overnight.
According to a Whitney Economics report last month, the ban "threatens to reduce retail revenues by $28.3 billion, displacing 225,000 jobs and reducing state sales tax potential by $2.1 billion."
The industry didn't appear from thin air. McConnell himself pushed industrial hemp legalization in the 2018 farm bill to give farmers a new cash crop. The law defined hemp as having less than 0.3% delta-9 THC by weight — language that allowed entrepreneurs to formulate beverages, gummies, and other products that met the letter of the law while delivering effects consumers wanted. Now Washington calls that a "loophole" and wants it shut.
Entrepreneurs who built businesses on that legal framework are staring at ruin. Nicholas Hohns, who makes THC gummies outside Raleigh, North Carolina, told ABC News: "It's such a weird spot to be in. You worked 100 hours a week for the past four years, and, yeah, you made some money. But now you might have nothing to show for it."
Eric Zipperle and Jim Higdon of Kentucky's Cornbread Hemp — 105 employees, products in 18 states, $65 million in expected revenue this year — said they'd accept a 5-milligram cap to stay alive. But 0.4 milligrams? "If it goes through in December, this place is toast — it's gone," Zipperle said.
The industry has offered to self-regulate: restrict products to adults 21 and older, cap THC per package, and ban imported cannabis compounds. ABC News reported that dozens of states have already regulated or banned impairing hemp products on their own — which raises the question of why Washington needs to step in at all.
President Trump signed a short-term funding bill that pushed the ban's effective date from November 12 to December 11, buying Congress time to choose regulation over prohibition.
Follow the money. When hemp-derived THC disappears, who benefits? Not the consumer who found relief outside the pharmaceutical walled garden. Not the small business owner. Not the state treasury losing $2.1 billion in tax revenue. The beneficiaries are the incumbents — licensed cannabis operators who don't want cheap competition, and a pharmaceutical industry that doesn't want Americans reaching for a hemp gummy instead of a prescription bottle.
The question Congress has to answer before December 11: Are you regulating an industry for safety, or killing it to protect someone else's market?
